Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 22 | 9 | 1,808 | 1,000 | 0 |
| Gross Profit | 22 | 9 | 1,808 | 1,000 | N/A |
| Operating Expenses | 7,382 | 6,032 | 6,979 | 9,396 | 8,989 |
| Operating Income | -7,360 | -6,023 | -5,172 | -8,396 | -8,989 |
| Other Income | 20,270 | -733 | 114 | 97 | 227 |
| Pre-tax Income | 12,911 | -6,755 | -5,058 | -8,299 | -8,762 |
| Net Income Continuous | 12,911 | -6,755 | -5,058 | -8,299 | -8,762 |
| Net Income | $12,911 | $-6,755 | $-5,058 | $-8,299 | $-8,762 |
| EPS Basic Total Ops | 1.53 | -0.81 | -0.76 | -1.09 | -1.22 |
| EPS Basic Continuous Ops | 1.54 | -0.81 | -0.71 | -1.09 | -1.22 |
| EPS Diluted Total Ops | 1.52 | -0.81 | -0.76 | -1.09 | -1.22 |
| EPS Diluted Continuous Ops | 1.52 | -0.81 | -0.71 | -1.09 | -1.22 |
| EPS Diluted Before Non-Recurring Items | 1.52 | -0.84 | -0.72 | N/A | N/A |
| EBITDA(a) | $-7,323 | $-6,011 | $-5,162 | $-8,387 | $-8,980 |